Global Drugs For Herpes Labialis (Oral Herpes) Market Analysis 2013-2018 and Forecast 2019-2024


Report - ID377748 | 09 January, 2019 | Healthcare | 111 pages | Report Type (Global) | Publisher Name - 99Strategy

Snapshot
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
The global Drugs For Herpes Labialis (Oral Herpes) market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs For Herpes Labialis (Oral Herpes) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Valacyclovir
        Aciclovir
        Famciclovir
    Docosanol
    Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
        GSK
        Novartis
        Teva
        Mylan
        Cadila
        Apotex
        Daewoong Pharmaceutical
        Livzon
        Luoxin
        Med shine
        Bayer (Campho Phenique)
        Blistex
        Kelun Group
        Hikma
        Haiwang
        Carmex
        Cipher
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
        External Use
        Oral
        Injection
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
        North America (U.S., Canada, Mexico)
        Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
        Asia-Pacific (China, India, Japan, Southeast Asia etc.)
        South America (Brazil, Argentina etc.)
        Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Content
1 Industry Overview
    1.1 Drugs For Herpes Labialis (Oral Herpes) Industry
        1.1.1 Overview
        1.1.2 Development of Drugs For Herpes Labialis (Oral Herpes)
    1.2 Market Segment
        1.2.1 Upstream
        1.2.2 Downstream
    1.3 Cost Analysis
2 Industry Environment
    2.1 Policy
    2.2 Economics
    2.3 Sociology
    2.4 Technology
3 Drugs For Herpes Labialis (Oral Herpes) Market by Type
    3.1 By Type
       3.1.1 Valacyclovir
       3.1.2 Aciclovir
       3.1.3 Famciclovir
       3.1.4 Docosanol
       3.1.5 Others
    3.2 Market Size
    3.3 Market Forecast
4 Major Companies List
    4.1 GSK (Company Profile, Sales Data etc.)
    4.2 Novartis (Company Profile, Sales Data etc.)
    4.3 Teva (Company Profile, Sales Data etc.)
    4.4 Mylan (Company Profile, Sales Data etc.)
    4.5 Cadila (Company Profile, Sales Data etc.)
    4.6 Apotex (Company Profile, Sales Data etc.)
    4.7 Daewoong Pharmaceutical (Company Profile, Sales Data etc.)
    4.8 Livzon (Company Profile, Sales Data etc.)
    4.9 Luoxin (Company Profile, Sales Data etc.)
    4.10 Med shine (Company Profile, Sales Data etc.)
    4.11 Bayer (Campho Phenique) (Company Profile, Sales Data etc.)
    4.12 Blistex (Company Profile, Sales Data etc.)
    4.13 Kelun Group (Company Profile, Sales Data etc.)
    4.14 Hikma (Company Profile, Sales Data etc.)
    4.15 Haiwang (Company Profile, Sales Data etc.)
    4.16 Carmex (Company Profile, Sales Data etc.)
    4.17 Cipher (Company Profile, Sales Data etc.)
5 Market Competition
    5.1 Company Competition
    5.2 Regional Market by Company
6 Market Demand
    6.1 Demand Situation
        6.1.1 Demand in External Use
        6.1.2 Demand in Oral
        6.1.3 Demand in Injection
    6.2 Regional Demand Comparison
    6.3 Demand Forecast
7 Region Operation
    7.1 Regional Production
    7.2 Regional Market
    7.3 by Region
        7.3.1 North America
            7.3.1.1 Overview
            7.3.1.2 by Country (U.S., Canada, Mexico)
        7.3.2 Europe
            7.3.2.1 Overview
            7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
        7.3.3 Asia-Pacific
            7.3.3.1 Overview
            7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
        7.3.4 South America
            7.3.4.1 Overview
            7.3.4.2 by Country (Brazil, Argentina etc.)
        7.3.5 Middle East & Africa
            7.3.5.1 Overview
            7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
    7.4 Regional Import & Export
    7.5 Regional Forecast
8 Marketing & Price
    8.1 Price and Margin
        8.1.1 Price Trends
        8.1.2 Factors of Price Change
        8.1.3 Manufacturers Gross Margin Analysis
    8.2 Marketing Channel
9 Research Conclusion
List of Tables

Table Upstream Segment of Drugs For Herpes Labialis (Oral Herpes)
Table Application Segment of Drugs For Herpes Labialis (Oral Herpes)
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2023, by Application, in USD Million
Table Major Company List of Valacyclovir
Table Major Company List of Aciclovir
Table Major Company List of Famciclovir
Table Major Company List of Docosanol
Table Major Company List of Others
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2013-2018, by Type, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2013-2018, by Type, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2019-2024, by Type, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2019-2024, by Type, in Volume
Table GSK Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cadila Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Livzon Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Livzon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luoxin Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Luoxin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Med shine Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Med shine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer (Campho Phenique) Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Bayer (Campho Phenique) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Blistex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Blistex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kelun Group Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Kelun Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Haiwang Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Haiwang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Carmex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Carmex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipher Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Cipher (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue 2013-2018, by Company, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share, by Company, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Volume 2013-2018, by Company, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Volume Share 2013-2018, by Company, in Volume
Table Drugs For Herpes Labialis (Oral Herpes) Demand in External Use, 2013-2018, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Demand in External Use, 2013-2018, in Volume
Table Major Consumers in External Use
Table Drugs For Herpes Labialis (Oral Herpes) Demand in Oral, 2013-2018, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Demand in Oral, 2013-2018, in Volume
Table Major Consumers in Oral
Table Drugs For Herpes Labialis (Oral Herpes) Demand in Injection, 2013-2018, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Demand in Injection, 2013-2018, in Volume
Table Major Consumers in Injection
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2019-2024, by Application, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2019-2024, by Application, in Volume
Table Drugs For Herpes Labialis (Oral Herpes) Production 2013-2018, by Region, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Production 2013-2018, by Region, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2013-2018, by Region, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Share 2013-2018, by Region, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2013-2018, by Region, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Share 2013-2018, by Region, in Volume
Table North America Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in USD Million
Table North America Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in Volume
Table Europe Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in USD Million
Table Europe Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in Volume
Table South America Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in USD Million
Table South America Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size 2013-2018, by Country, in Volume
Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2019-2024, by Region, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List


List of Figures

Figure Drugs For Herpes Labialis (Oral Herpes) Industry Chain Structure
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2013-2018, by Type, in USD Million
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2013-2018, by Type, in Volume
Figure North America Drugs For Herpes Labialis (Oral Herpes) Market, by Company, in 2018
Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2018
Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2018
Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2018
Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2018
Figure North America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in USD Million
Figure North America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in Volume
Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in USD Million
Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in Volume
Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in USD Million
Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
Leave a Message